Abstracts 1315 to 1481, LB6–LB15
19 September 2007
Hemochromatosis genotypes and risk of 31 disease endpoints: Meta‐analyses including 66,000 cases and 226,000 controls
Christina Ellervik, Henrik Birgens, Anne Tybjærg‐Hansen, Børge G. Nordestgaard – 7 September 2007 – Hemochromatosis genotypes have been associated with liver disease, diabetes mellitus, heart disease, arthritis, porphyria cutanea tarda, stroke, neurodegenerative disorders, cancer, and venous disease.
Transient left ventricular apical ballooning syndrome (Takotsubo cardiomyopathy) following orthotopic liver transplantation
Howard R. Lee, R. Todd Hurst, Hugo E. Vargas – 30 August 2007
Malaria infection through multiorgan donation: An update from Spain
Monserrat Rodriguez, Santiago Tome, Luis Vizcaino, Javier Fernandez‐Castroagudin, Esteban Otero‐Anton, Esther Molina, Jorge Martinez, Gloria De la Rosa, Jose Lovo, Evaristo Varo – 30 August 2007 – During the last years, immigration has increased and, consequently, the pool of foreign donors and associated infectious diseases from exotic countries (especially from the tropics) has also increased. Only a few cases of malaria transmitted via different donation sources have been published. In the present report, a Plasmodium vivax transmitted through a multiorgan donation is reported.
Application of intraoperative cine‐portogram to detect spontaneous portosystemic collaterals missed by intraoperative doppler exam in adult living donor liver transplantation
Deok‐Bog Moon, Sung‐Gyu Lee, ChulSoo Ahn, Shin Hwang, Ki‐Hun Kim, TaeYong Ha, GiWon Song, JeHo Ryu, KyuBo Sung, GiYoung Ko – 30 August 2007 – Adequate portal inflow is essential to the regeneration of a partial liver graft after adult living donor liver transplantation (LDLT).
Long‐term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation
Phunchai Charatcharoenwitthaya, Sylvania Pimentel, Jayant A. Talwalkar, Felicity T. Enders, Keith D. Lindor, Ruud A.F. Krom, Russell H. Wiesner – 30 August 2007 – The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long‐term follow‐up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known.
How, why, and when does primary biliary cirrhosis recur after liver transplantation?
- Read more about How, why, and when does primary biliary cirrhosis recur after liver transplantation?
Roger Williams, M. Eric Gershwin – 30 August 2007
Predicting outcome in acute liver failure: Are we there yet?
Gerry MacQuillan – 30 August 2007
Successful long‐term repair of hepatic artery pseudoaneurysm following liver transplantation with primary stent‐grafting
Georg Elias, Cristiana Rastellini, Hannan Nsier, Pradeep Nazarey, Melissa Brown, Mohan Pahari, Lawton Shick, Ducksoo Kim, Luca Cicalese – 30 August 2007
Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis
Dimitrios N. Samonakis, Evangelos Cholongitas, Ulrich Thalheimer, George Kalambokis, Alberto Quaglia, Christos K. Triantos, Maria Mela, Penelope Manousou, Marco Senzolo, Amar Paul Dhillon, David Patch, Andrew Kenneth Burroughs – 30 August 2007 – Progression of fibrosis following recurrent hepatitis C virus (HCV) infection is frequent after liver transplantation (LT). Histology remains the gold standard to assess fibrosis, but the value of hepatic venous pressure gradient (HVPG) is being explored.